Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
Cambridge, MA NAICS: 541714
U.S. Department of Labor's OFLC discloses 19 Labor Condition Application filings naming BlueRock Therapeutics, LP from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 11 H-1B petitions naming BlueRock Therapeutics, LP through FY2024, and approved nearly every one of them: 100% approved (11 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
BlueRock Therapeutics, LP is listed in 19 DOL LCA filings, more filings than 91% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $159,373. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Cambridge, MA.
BlueRock Therapeutics, LP vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
19 11817th of 122824 higher than 111,007 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $85,500–$230,000 .
On 19 LCAs with comparable offered vs prevailing wages, BlueRock Therapeutics, LP averages about 23.3% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Qualified (Level II) (52.6% of LCA filings).
Certification Rate
100%
Very high DOL cert
Avg. Salary
$159,373
Well above portal avg
Total Workers
19
Small worker count
Compensation range for H-1B positions at BlueRock Therapeutics, LP
Wage vs. DOL Minimum
+23.3%
Above DOL floor
national avg +17.8%
Typical DOL Wage Level
Qualified (Level II)
52.6% of LCA filings
Full-Time Positions
100%
Primary Worksite County
CAMBRIDGE CITY, MA
57.9% of LCA filings
Most frequently listed job titles at BlueRock Therapeutics, LP
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Data Architect (00097205) | 2 | $184,995 |
| Director, Pharmacovigilance Scientist (00096962) | 2 | $215,000 |
| Specialist III, Computational Core | 1 | $115,000 |
| Specialist II, Lab Operations | 1 | $85,500 |
| Senior Scientist In Vivo Immunology | 1 | $140,000 |
| Senior Manager, CMC Program Management | 1 | $180,000 |
| Senior Data Architect, Research Solutions, IT | 1 | $190,000 |
| Scientist II, Editing Reagents & Analytics | 1 | $122,500 |
| Scientist I, Process Development | 1 | $110,000 |
| Scientist I, Analytical & Quality Control (00102862) | 1 | $113,464 |
| Research Associate II, Discovery Analytics | 1 | $99,840 |
| Manager, Regulatory Affairs Strategy | 1 | $145,000 |
| Director, Research (00102861) | 1 | $192,000 |
| Director, Biostatistics | 1 | $230,000 |
| Clinical Trial Coordinator | 1 | $129,792 |
Cross-state DOL neighbors for BlueRock Therapeutics, LP - LCA filing-count and offered-wage axes, outside MA.
Nearest cross-state employer filers by LCA filing count (19 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($159,373 here).
BlueRock Therapeutics, LP is listed in 19 DOL Labor Condition Application filings covering 19 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, BlueRock Therapeutics, LP ranks #11322 by total LCA filing count (19 filings). 111,007 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
BlueRock Therapeutics, LP has a 100% DOL certification rate, with 19 out of 19 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in BlueRock Therapeutics, LP's LCAs is $159,373. Listed wages range from $85,500 to $230,000 and are not verified actual compensation.
The top job titles in BlueRock Therapeutics, LP's LCA filing records include Senior Data Architect (00097205), Director, Pharmacovigilance Scientist (00096962), Specialist III, Computational Core. The most common listed title is Senior Data Architect (00097205) with 2 LCA filings at an average listed offered wage of $184,995. This does not establish actual job openings, hiring, or approved petitions.
BlueRock Therapeutics, LP is headquartered in Cambridge, MA. Their H-1B workers are distributed across 2 states, with the most positions in MA, NY.
No, BlueRock Therapeutics, LP is not classified as H-1B dependent.
BlueRock Therapeutics, LP is listed in 6 LCA filings in FY2023 and 6 in FY2026. The average listed offered wage increased from $128,000 to $184,242. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 19 LCAs (Δ 0 heavier vs BlueRock Therapeutics, LP); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 19 LCAs (Δ 0 heavier vs BlueRock Therapeutics, LP); CERT-LOCK · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 19 LCAs (Δ 0 heavier vs BlueRock Therapeutics, LP); CERT-SOFT · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 19 LCAs (Δ 0 heavier vs BlueRock Therapeutics, LP); CERT-SOLID · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
MA pole at 3,809 LCAs stamps HEAVY-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from BlueRock Therapeutics, LP's MICRO-BOOK.
Open the MA state board after the ABS peers. BlueRock Therapeutics, LP stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
BlueRock Therapeutics, LP's WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for BlueRock Therapeutics, LP to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.